8 Avocado rhizobacteria emit volatile organic compounds with antifungal activity against Fusarium solani, Fusarium sp. associated with Kuroshio shot hole borer, and Colletotrichum gloeosporioides.

9 Maturity, storage and ripening effects on anti-fungal compounds in the skin of ‘Hass’ avocado fruit

10 Silver nanoparticles coated with dodecanethiol used as fillers in non-cytotoxic and antifungal PBAT surface based on nanocomposites.

11 Natural and recombinant fungal laccases for paper pulp bleaching.

12 Novel fungal metabolites as cell wall active antifungals: Fermentation, isolation, physico-chemical properties, structure and biological activity

13 β-glucan: Crucial component of the fungal cell wall and elusive MAMP in plants

14 Synthesis of 2,3-Dihydro Flavone Coumarins as a Class of Potent Antifungal and Anti-inflammatory Agents

15 Invasive Aspergillosis by : Epidemiology, Diagnosis, Antifungal Resistance, and Management.

16 Antifungal synergy of a topical triazole, PC945, with a systemic triazole against respiratory Aspergillus fumigatus infection.

17 Pyocyanin, a Metabolite of Pseudomonas Aeruginosa, Exhibits Antifungal Drug Activity Through Inhibition of a Pleiotropic Drug Resistance Subfamily FgABC3.

18 Coumarins from the peel of citrus grown in Colombia: composition, elicitation and antifungal activity.

19 The multivariate statistical selection of fungal strains isolated from Neoteredo reynei, with the high hydrolytic potential to deconstruct cellulose.

20 Pythiosis: case report leading to new features in clinical and diagnostic management of this fungal-like infection.

21 Antifungal spectrum characterization and identification of strong volatile organic compounds produced by TM-R.

22 Extended Dosing Regimens for Fungal Prophylaxis.

23 Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.

24 Globally invading populations of the fungal plant pathogen Verticillium dahliae are dominated by multiple divergent lineages.

25 Antifungal activity of chestnut shell extracts

26 Fungal Opportunistic Pneumonias in HIV/AIDS Patients: An Indian Tertiary Care Experience.

27 Evaluation of 1,3-benzoxathiol-2-one Derivatives as Potential Antifungal Agents.

28 Antifungal action of the oxathiolone-fused chalcone derivative.

29 Cytotoxic and Antifungal Activities of 5-Hydroxyramulosin, a Compound Produced by an Endophytic Fungus Isolated from Cinnamomum mollisimum

30 Grains colonised by moulds: fungal identification and headspace analysis of produced volatile metabolites

31 The fungal gene cluster for biosynthesis of the antibacterial agent viriditoxin.

32 Evaluating the outcomes of submerged co-cultivation: production of lovastatin and other secondary metabolites by Aspergillus terreus in fungal co-cultures

33 Antifungal and antimycotoxigenic metabolites from native plants of northwest Argentina: isolation, identification and potential for control of Aspergillus species

34 Synthesis, Antifungal Activity and Structure-Activity Relationships of Novel 3-(Difluoromethyl)-1-methyl-1H-pyrazole-4-carboxylic Acid Amides

35 In Vitro Activities of 15 Antifungal Drugs against a Large Collection of Clinical Isolates of Microsporum canis.

36 Investigation on 4-amino-5-substituent-1,2,4-triazole-3-thione Schiff bases an antifungal drug by characterization (spectroscopic, XRD), biological activities, molecular docking studies and electrostatic potential (ESP)

37 efficacy of chlorhexidine and a riboflavin/UVA combination on fungal agents of keratitis.

38 Emergence of Fungal-Like Organisms: Prototheca.

39 National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice

40 Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology

41 Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology

42 The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian model

43 From the clinical mycology laboratory: New species and changes in fungal taxonomy and nomenclature

44 Onychomycosis: Which fungal species are involved? Experience of the Laboratory of Parasitology-Mycology of the Rabta Hospital of Tunis

45 Effects of Several Common Antifungal Drugs (Clotrimazole, Miconazole, Fluconazole) alone and in Combination with Amphotericin B on Candida Species Isolated from Chronic Candidal Vulvovaginitis

46 Bacillomycin D and its combination with amphotericin B: Promising antifungal compounds with powerful antibiofilm activity and wound-healing potency

47 Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility

48 Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis

49 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

50 Identification and antifungal susceptibility profiles of Kodamaea ohmeri based on a seven-year multicenter surveillance study

51 Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis

52 A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections

53 Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis

54 Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

55 Current trends to control fungal pathogens: exploiting our knowledge in the host–pathogen interaction

56 Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar

57 New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China

58 Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies

59 Invasive Aspergillus terreus morphological transitions and immunoadaptations mediating antifungal resistance

60 Antifungal resistance: current trends and future strategies to combat

61 Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

62 A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections

63 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

64 Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections

65 Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

66 Update on the optimal use of voriconazole for invasive fungal infections

67 Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility

68 Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis

69 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

70 Identification and antifungal susceptibility profiles of Kodamaea ohmeri based on a seven-year multicenter surveillance study

71 Prevalence of Candida blood stream infections among children in tertiary care hospital: detection of species and antifungal susceptibility

72 Efficacy of humanized single large doses of caspofungin on the lethality and fungal tissue burden in a deeply neutropenic murine model against Candida albicans and Candida dubliniensis

73 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

74 Identification and antifungal susceptibility profiles of Kodamaea ohmeri based on a seven-year multicenter surveillance study

75 Bioremoval of Cobalt(II) from Aqueous Solution by Three Different and Resistant Fungal Biomasses

76 Comparative effectiveness of antifungal agents in patients with hematopoietic stem cell transplantation: a systematic review and network meta-analysis

77 A study on biofilm production and antifungal drug resistance among Candida species from vulvovaginal and bloodstream infections

78 Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis

79 Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

80 Current trends to control fungal pathogens: exploiting our knowledge in the host–pathogen interaction

81 Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar

82 New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China

83 Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies

84 Invasive Aspergillus terreus morphological transitions and immunoadaptations mediating antifungal resistance

85 Antifungal resistance: current trends and future strategies to combat

86 Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

87 A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections

88 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

89 Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections

90 Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

91 Update on the optimal use of voriconazole for invasive fungal infections

92 Bioremoval of Different Heavy Metals by the Resistant Fungal Strain Aspergillus niger

93 Effect of milling, fermentation or roasting on water activity, fungal growth, and aflatoxin contamination of Bambara groundnut (Vigna subterranea (L.) Verdc)

94 Antifungal activity and tautomeric cyclization equilibria of formylphenylboronic acids.

95 [Factors related to oral candidiasis in HIV children and adolescents, species characterization and antifungal susceptibility].

96 Fungal bioprospecting and antifungal treatment on a deteriorated Brazilian contemporary painting.

97 Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity.

98 Effect of seasonality on chemical profile and antifungal activity of essential oil isolated from leaves Psidium salutare (Kunth) O. Berg

99 Antifungal activity of volatile emitted from Enterobacter asburiae Vt-7 against Aspergillus flavus and aflatoxins in peanuts during storage

100 Development of an ultrasensitive label-free immunosensor for fungal aflatoxin B1 detection

101 Influência da calagem, da época de colheita e da secagem na incidência de fungos e aflatoxinas em grãos de amendoim armazenados Storage peanut kernels fungal contamination and aflatoxin as affected by liming, harvest time and drying

Keyword Connections

Journals

Research Groups

Bibliographies